Search Results 71-80 of 16850 for CLL
-
... Chronic Lymphocytic Leukemia (CLL) with controls from a normal household and age-matched population. Participation eligibility. Participant eligibility ...
-
... Chronic Lymphocytic Leukemia (CLL)/ Non-Hodgkins Lymphoma (NHL). Print ... chronic lymphocytic leukemia (CLL)/non-Hodgkin lymphoma (NHL). The study will ...
-
This medicine is also used to treat chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). Zanubrutinib is also used in combination with ...
-
The purpose of this study is to define the presence and role of Axl in the risk of skin cancers in patients with CLL as well as non-CLL patients.
-
Given that family members of CLL patients are known to have an increased risk of CLL (on the order of 8-fold), and they have a higher prevalence of MBL than in ...
-
Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small ...
-
... Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL). Print ... Cohort 4 only: Previously treated subjects with active CLL/SLL with ...
-
It is used to treat a type of cancer of the white blood cells called B-cell chronic lymphocytic leukemia (CLL). This medicine is used in patients with CLL ...
-
... chronic lymphocytic leukemia (CLL). This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and ...
-
... chronic lymphocytic leukemia (B-CLL). Biological therapies, such as lenalidomide, may stimulate the immune system in different ways and stop cancer cells ...